User profiles for R. Duarte
Ricardo DuarteHead Coach at IF Gnistan Verified email at footballdynamics.net Cited by 5075 |
Towards tuberculosis elimination: an action framework for low-incidence countries
…, L De Paoli, HM Dias, R Duarte… - European …, 2015 - Eur Respiratory Soc
This paper describes an action framework for countries with low tuberculosis (TB) incidence
(<100 TB cases per million population) that are striving for TB elimination. The framework …
(<100 TB cases per million population) that are striving for TB elimination. The framework …
[HTML][HTML] Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects
…, L D'ambrosio, B Chen, J Mueller, P Mueller, R Duarte… - Pulmonology, 2021 - Elsevier
Evidence is accumulating on the interaction between tuberculosis (TB) and COVID-19. The
aim of the present review is to report the available evidence on the interaction between these …
aim of the present review is to report the available evidence on the interaction between these …
Indications for allo-and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
This is the sixth special report that the European Society for Blood and Marrow Transplantation
regularly publishes on the current practice and indications for haematopoietic SCT for …
regularly publishes on the current practice and indications for haematopoietic SCT for …
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a …
…, B Doganov, L Dreosti, R Duarte, R Edusma-Dy… - The Lancet, 2019 - thelancet.com
Background First-line pembrolizumab monotherapy improves overall and progression-free
survival in patients with untreated metastatic non-small-cell lung cancer with a programmed …
survival in patients with untreated metastatic non-small-cell lung cancer with a programmed …
[HTML][HTML] National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and …
…, GS Cheng, H Kerr, P Stratton, RF Duarte… - Biology of Blood and …, 2015 - Elsevier
The 2005 National Institutes of Health (NIH) Consensus Conference proposed new criteria
for diagnosing and scoring the severity of chronic graft-versus-host disease (GVHD). The …
for diagnosing and scoring the severity of chronic graft-versus-host disease (GVHD). The …
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement
…, PJ Cardona, B Kan, I Solovic, R Duarte… - European …, 2009 - Eur Respiratory Soc
Tuberculosis control relies on the identification and preventive treatment of individuals who
are latently infected with Mycobacterium tuberculosis. However, direct identification of latent …
are latently infected with Mycobacterium tuberculosis. However, direct identification of latent …
[HTML][HTML] Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation
…, J Maertens, SS Dadwal, RF Duarte… - … England Journal of …, 2017 - Mass Medical Soc
Background Cytomegalovirus (CMV) infection remains a common complication after allogeneic
hematopoietic-cell transplantation. Letermovir is an antiviral drug that inhibits the CMV–…
hematopoietic-cell transplantation. Letermovir is an antiviral drug that inhibits the CMV–…
[PDF][PDF] Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer
…, T Pintér, S Van Belle, D Vorobiof, R Duarte… - Journal of Clinical …, 1999 - academia.edu
Purpose: This phase III study compared docetaxel and doxorubicin in patients w ith metastatic
breast cancer w ho had received previousalkylating agent–containing chemotherapy. …
breast cancer w ho had received previousalkylating agent–containing chemotherapy. …
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
Anti-tumour necrosis factor (TNF) monoclonal antibodies or soluble TNF receptors have
become an invaluable treatment against chronic inflammatory diseases, such as rheumatoid …
become an invaluable treatment against chronic inflammatory diseases, such as rheumatoid …
[HTML][HTML] COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
Background Patients with hematological malignancies (HM) are at high risk of mortality from
SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse …
SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse …